Bulk deals : Vanguard Group buys shares worth Rs 1000 crore in 7 companies
On September 20, Vanguard Group bought shares worth around Rs 1000 crore in seven Indian listed companies via a bulk deal. Along with this, UBS Principal Capital Asia Limited sold stakes in various companies on the same day. The Vanguard Group Inc A/C Vanguard Total International Stock Index Fund
Vanguard sells shares of 7 companies worth Rs 998 cr via block deals
US-based financial services company Vanguard Group on Friday bought shares of seven companies including Concord Biotech, Five-Star Business Finance and Marksans Pharma for Rs 998 crore through open market transactions.
UBS sells shares worth Rs 480 crore in Concord Biotech, IIFL Securities, 2 more stocks via block deals
UBS sold holdings in Concord Biotech, Five Star Business Finance, IIFL Securities, and Marksans Pharma through block deals, totaling Rs 480 crore. The largest sale was in Concord Biotech, worth Rs 192 crore at a 15% premium.
Vanguard Group Buys Rs 998 Cr Shares in 7 Companies
Vanguard Group, a US-based financial services company, has purchased shares in seven Indian companies, including Concord Biotech and Five-Star Business Finance, for a total of Rs 998 crore.
Vanguard Group Acquires Rs 998 Crore in Indian Companies
US-based financial services company Vanguard Group acquired shares worth Rs 998 crore in seven Indian companies via open market transactions on the NSE. Concurrently, Zurich-based UBS Group AG sold shares worth Rs 479.
UBS Offloads Shares Worth Rs 480 Crore In Four Companies
UBS Principal Capital Asia Ltd. sold stakes in Concord Biotech Ltd., Five-Star Bus Fin Ltd., IIFL Securities Ltd. and Marksans Pharma Ltd. worth Rs 480 crore, according to the bulk deal data on the NSE. Concord had 7.4 lakh shares sold by UBS, representing a 0.7% stake at Rs 2589.86 apiece, aggregating to a total value of 191 crore.
Breakout stocks to buy or sell: Reliance Infra to Prism Johnson — Sumeet Bagadia recommends five shares to buy today
Sumeet Bagadia recommends five shares to buy today — Marksans Pharma, Concord Biotech, Magadh Sugar, Prism Johnson, and ...
Morningstar5d
Marksans Pharma Ltd
We sell different types of products and services to both investment professionals and individual investors. These products and services are usually sold through license agreements or subscriptions ...
Stock market update: Stocks that hit 52-week highs on NSE in today's trade
Marksans Pharma, Concord Biotech Ltd., Interarch Building and Themis Medicare, hit their fresh 52-week highs during the day.
Wall Street Journal8d
Marksans Pharma Ltd.
The Price to Earnings (P/E) ratio, a key valuation measure, is calculated by dividing the stock's most recent closing price by the sum of the diluted earnings per share from continuing operations ...